Kinnate Biopharma

Acquired

San Diego, United States · Founded 2018 · $146.0M raised

Headquarters
San Diego
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$146.0M
Last Round
$98.0M Series CAug 2020
Rounds
2
Acquired by
XOMAJan 2024

About

Kinnate Biopharma was a clinical-stage precision oncology company based in San Diego, California, founded in 2018, that designed small-molecule kinase inhibitors targeting oncogenic drivers such as RAF and FGFR for patients whose cancers had progressed on prior therapies. The company went public on Nasdaq in 2020, cut 70% of its workforce in a September 2023 restructuring, sold its lead pan-RAF program exarafenib to Pierre Fabre Laboratories in March 2024, and was acquired by XOMA Corporation the same year, ending independent operations.

Summary

Kinnate Biopharma is a Biotech company based in San Diego, United States, founded in 2018. It has raised $146.0M in total across 2 rounds, most recently a $98.0M Series C round in Aug 2020.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionJan 2024

Sign up to see all 4 rounds

Series A through Acquisition — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kinnate Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/kinnate-biopharma"><img src="https://indexed.vc/api/badge/company/kinnate-biopharma" alt="Kinnate Biopharma on Indexed.vc" width="260" height="76" /></a>